Evidence map›Paper›PMID 39891244›Full record

ArticleJournal of cheminformatics2025

MLinvitroTox reloaded for high-throughput hazard-based prioritization of high-resolution mass spectrometry data.

Katarzyna Arturi, Eliza J Harris, Lilian Gasser, Beate I Escher, Georg Braun, Robin Bosshard, Juliane Hollender

Registry-linked trialAbstract read
In one paragraph

Article in Journal of cheminformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07360691 (Early Clinical Outcomes of High-Purity Type I Collagen as a Biologic Reinforcement in Selected Hernia Repair Scenarios), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07360691 nacompletednot on this mapstarted 2026, after this paper: background citation

Early Clinical Outcomes of High-Purity Type I Collagen as a Biologic Reinforcement in Selected Hernia Repair Scenarios: A Prospective Clinical Study

TypeinterventionalSponsorAdichunchanagiri Institute of Medical Sciences, B G NagaraRan2026 to 2026Enrolled30ConditionsHernia, Ventral Hernia, Incisional Hernia, İnguinal HerniaArmsHigh-Purity Type I Collagen Mesh
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Will Chemical Exposomics Be Ready for a Human Exposome Project?Environmental science & technology · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katarzyna ArturiDepartment of Environmental Chemistry, Swiss Federal Institute of Aquatic Science and Technology (Eawag), Überlandstrasse 133, 8600, Dübendorf, Switzerland. kasia.arturi@eawag.ch.
Eliza J HarrisSwiss Data Science Center (SDSC), Andreasstrasse 5, 8092, Zürich, Switzerland.
Lilian GasserSwiss Data Science Center (SDSC), Andreasstrasse 5, 8092, Zürich, Switzerland.
Beate I EscherCell Toxicology, Helmholtz Centre for Environmental Research (UFZ), Permoserstr. 15, 04318, Leipzig, Germany.
Georg BraunCell Toxicology, Helmholtz Centre for Environmental Research (UFZ), Permoserstr. 15, 04318, Leipzig, Germany.
Robin BosshardDepartment of Computer Science, Eidgenössische Technische Hochschule Zürich (ETH Zürich), Universitätstrasse 6, 8092, Zürich, Switzerland.
Juliane HollenderDepartment of Environmental Chemistry, Swiss Federal Institute of Aquatic Science and Technology (Eawag), Überlandstrasse 133, 8600, Dübendorf, Switzerland. juliane.hollender@eawag.ch.

Funding

HORIZON EUROPE European Research Council 101057014Swiss Data Science Center C21-01
6 · The paper itself

Abstract

MLinvitroTox is an automated Python pipeline developed for high-throughput hazard-driven prioritization of toxicologically relevant signals detected in complex environmental samples through high-resolution tandem mass spectrometry (HRMS/MS). MLinvitroTox is a machine learning (ML) framework comprising 490 independent XGBoost classifiers trained on molecular fingerprints from chemical structures and target-specific endpoints from the ToxCast/Tox21 invitroDBv4.1 database. For each analyzed HRMS feature, MLinvitroTox generates a 490-bit bioactivity fingerprint used as a basis for prioritization, focusing the time-consuming molecular identification efforts on features most likely to cause adverse effects. The practical advantages of MLinvitroTox are demonstrated for groundwater HRMS data. Among the 874 features for which molecular fingerprints were derived from spectra, including 630 nontargets, 185 spectral matches, and 59 targets, around 4% of the feature/endpoint relationship pairs were predicted to be active. Cross-checking the predictions for targets and spectral matches with invitroDB data confirmed the bioactivity of 120 active and 6791 nonactive pairs while mislabeling 88 active and 56 non-active relationships. By filtering according to bioactivity probability, endpoint scores, and similarity to the training data, the number of potentially toxic features was reduced by at least one order of magnitude. This refinement makes the analytical confirmation of the toxicologically most relevant features feasible, offering significant benefits for cost-efficient chemical risk assessment.Scientific Contribution:In contrast to the classical ML-based approaches for toxicity prediction, MLinvitroTox predicts bioactivity for HRMS features (i.e., distinct m/z signals) based on MS2 fragmentation spectra rather than the chemical structures from the identified features. While the original proof of concept study was accompanied by the release of a MLinvitroTox v1 KNIME workflow, in this study, we release a Python MLinvitroTox v2 package, which, in addition to automation, expands functionality to include predicting toxicity from structures, cleaning up and generating chemical fingerprints, customizing models, and retraining on custom data. Furthermore, as a result of improvements in bioactivity data processing, realized in the concurrently released pytcpl Python package for the custom processing of invitroDBv4.1 input data used for training MLinvitroTox, the current release introduces enhancements in model accuracy, coverage of biological mechanistic targets, and overall interpretability.

Indexed as

Activity predictionBinary classificationHRMS/MSIn vitro assaySIRIUSTox21ToxCastToxicityXGBoost

Identifiers

PMID39891244
PMCPMC11786476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.